# Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation

> **NCT00128739** · PHASE3 · COMPLETED · sponsor: **Rafa Laboratories** · enrollment: 24 (—)

## Conditions studied

- Graft Vs Host Disease

## Interventions

- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT00128739
- **Lead sponsor:** Rafa Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 24 (—)
- **Last updated:** 2005-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00128739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00128739, "Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00128739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*